| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 22 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Gross Profit/Loss - EUR | -22 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Net Profit/Loss - EUR | -22 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - Bioselios S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | 3.460 | 3.425 | 3.367 | 3.305 | 3.241 | 3.180 | 3.109 | - | - | - |
| Inventories | 3.323 | 3.289 | 3.233 | 3.174 | 3.112 | 3.053 | 2.986 | - | - | - |
| Receivables | 26 | 26 | 25 | 25 | 24 | 24 | 23 | - | - | - |
| Cash | 112 | 110 | 109 | 107 | 105 | 103 | 100 | - | - | - |
| Shareholders Funds | 2.133 | 2.111 | 2.075 | 2.037 | 1.998 | 1.960 | 1.916 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 1.328 | 1.314 | 1.292 | 1.268 | 1.244 | 1.220 | 1.193 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Bioselios S.r.l.